While the precise molecular mechanisms remain unclear, these findings highlight the intricate role of LCN2 in astrocyte-mediated cognitive decline and suggest potential therapeutic avenues for targeting specific astrocyte activation phenotypes. Here, LCN2 is linked to Mental deterioration.